Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine Prolong vs Risperidone in Acute Schizophrenia
NCT00660595Phase 3Terminated
- Sponsor
- AstraZeneca
- Start
- Sep 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine (extended-release tablet, brand name: Bipresso) in schizophrenia, schizoaffective disorder, schizophreniform disorder, sponsored by AstraZeneca. Started Sep 2008; status: terminated.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorder
Beyond the preview
Go deeper on NCT00660595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660595.